STOCK TITAN

Recursion to Participate in Upcoming Investor Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Recursion (RXRX), a clinical stage TechBio company focused on drug discovery, has announced its upcoming participation in the Needham 24th Annual Virtual Healthcare Conference scheduled for April 7, 2025.

Investors and interested parties can access the conference webcasts through the events section of Recursion's Investor Relations website at ir.recursion.com.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-3.69% News Effect

On the day this news was published, RXRX declined 3.69%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Salt Lake City, UT, April 01, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today its participation in the following upcoming investor conference:

  • Needham 24th Annual Virtual Healthcare Conference — Monday, April 7, 2025

Webcasts may be found in the events section of the Recursion Investor Relations website at ir.recursion.com.

About Recursion
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.
Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montréal, New York, London, Oxford area, and the San Francisco Bay area. Learn more at www.Recursion.com, or connect on X (formerly Twitter) and LinkedIn.



Media Contact
Media@Recursion.com

Investor Contact
Investor@Recursion.com

FAQ

When is Recursion (RXRX) presenting at the Needham Healthcare Conference 2025?

Recursion (RXRX) will present at the Needham 24th Annual Virtual Healthcare Conference on Monday, April 7, 2025.

How can investors access Recursion's (RXRX) Needham Conference presentation?

Investors can access the webcast through the events section of Recursion's Investor Relations website at ir.recursion.com.

What type of conference is Recursion (RXRX) participating in April 2025?

Recursion is participating in the Needham 24th Annual Virtual Healthcare Conference, a virtual investor conference focused on healthcare.

Is Recursion's (RXRX) Needham Conference presentation virtual or in-person?

The presentation will be virtual as part of the Needham 24th Annual Virtual Healthcare Conference.
Recursion Pharmaceuticals, Inc.

NASDAQ:RXRX

RXRX Rankings

RXRX Latest News

RXRX Latest SEC Filings

RXRX Stock Data

2.31B
494.17M
4.74%
69.3%
28.42%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SALT LAKE CITY